463
Views
30
CrossRef citations to date
0
Altmetric
Research Article

An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA

, , , &
Pages 1677-1683 | Received 18 Sep 2012, Accepted 14 Dec 2012, Published online: 07 Feb 2013

References

  • Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992;16:637–640.
  • Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265–276.
  • Groves FD, Linet MS, Travis LB, et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92: 1240–1251.
  • Li JY, Gaillard F, Moreau A, et al. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999;154:1449–1452.
  • Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol 2011;21:293–298.
  • Zhou Y, Wang H, Fang W, et al. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 2008;113:791–798.
  • Barouk-Simonet E, Andrieux J, Copin MC, et al. TPA stimulation culture for improved detection of t(11;14)(q13;q32) in mantle cell lymphoma. Ann Genet 2002;45:165–168.
  • Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 2002;33:7–20.
  • US National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) limited-use data set. November 2011. Available from: http://seer.cancer.gov/data/
  • Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer 1995;76:2343–2350.
  • Surveillance Research Program. 2012 National Cancer Institute SEER*Stat software, version 7.0.6. Available from: www.seer.cancer.gov/seerstat
  • Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Commun Stat Theory Methods 1999;28:2141–2160.
  • Fay MP, Tiwari RC, Feuer EJ, et al. Estimating average annual percent change for disease rates without assuming constant change. Biometrics 2006;62:847–854.
  • Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18:177–187.
  • Nambiar M, Raghavan SC. Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population. Ann Hematol 2010;89:35–43.
  • Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003;36:211–223.
  • Dölken G, Dölken L, Hirt C, et al. Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. J Natl Cancer Inst Monogr 2008;(39): 44–47.
  • Lecluse Y, Lebailly P, Roulland S, et al. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 2009;23:1190–1193.
  • Smith MR, Joshi I, Jin F, et al. Murine model for mantle cell lymphoma. Leukemia 2006;20:891–893.
  • Chiu BC, Dave BJ, Blair A, et al. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood 2006;108:1363–1369.
  • Schroeder JC, Olshan AF, Baric R, et al. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma. Epidemiology 2001;12:701–709.
  • Chiu BC, Lan Q, Dave BJ, et al. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J Natl Cancer Inst Monogr 2008;39:69–73.
  • Davis DL, Rall DP. Approach to prevention. In: Rosenstock L, Cullen MR, editors. Textbook of clinical occupational and environmental medicine. Philadelphia: Saunders; 1994. pp. 615–620.
  • Day NE, Charnay B. Time trends, cohort effects, and aging as influence on cancer incidence. In: Magnus K, editor. Trends in cancer incidence: causes and practical implications. Washington, DC: Hemisphere; 1982. pp. 51–65.
  • Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 1998;23:1–6.
  • Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469–1476.
  • Pérez-Galán P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 2011;117:26–38.
  • Martin P, Smith M, Till B. Management of mantle cell lymphoma in the elderly. Best Pract Res Clin Haematol 2012;25: 221–231.
  • Overview of the SEER Program. National Cancer Institute Surveillance Epidemiology and End Results. Available from: http://seer.cancer.gov/about/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.